EP2379104
Sprautanlegar formúlur af Bótúlíneitri
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.12.2009EP published:
28.2.2018EP application number:
09837072.9
EP translation filed:
23.3.2018Grant published:
15.5.2018EPO information:
European Patent Register
Max expiry date:
27.12.2029Expiry date:
27.12.2026Next due date:
31.12.2026
Title:
INJECTABLE BOTULINUM TOXIN FORMULATIONS
Timeline
Today
28.12.2009EP application
28.2.2018EP Publication
23.3.2018Translation submitted
15.5.2018Registration published
27.12.2026Expires
Owner
Name:
Revance Therapeutics, Inc.Address:
7555 Gateway Boulevard, 94560, Newark, CA, US
Inventor
Name:
RUEGG, Curtis, L.Address:
Redwood CityCA, US
Name:
STONE, Hongran, F.Address:
Menlo ParkCA, US
Name:
WAUGH, Jacob, M.Address:
San FranciscoCA, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
142063 PDate:
31.12.2008Country:
US
Classification
Categories:
A61K 39/08, A61K 8/64, A61Q 19/08
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 31.12.2018
Expires: 27.12.2019
Payer: Árnason Faktor
Number: 11
Paid: 31.12.2019
Expires: 27.12.2020
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.11.2020
Expires: 27.12.2021
Payer: Örn Þór slf.
Number: 13
Paid: 9.6.2022
Expires: 27.12.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 10.11.2022
Expires: 27.12.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 6.11.2023
Expires: 27.12.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 11.11.2024
Expires: 27.12.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 7.11.2025
Expires: 27.12.2026
Payer: Árnason Faktor ehf.